查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
微載體市場規模和預測、全球和地區佔有率、趨勢以及按產品、設備、應用、最終用戶和地理位置進行的成長機會分析
市場調查報告書
商品編碼
1389605

微載體市場規模和預測、全球和地區佔有率、趨勢以及按產品、設備、應用、最終用戶和地理位置進行的成長機會分析

Microcarriers Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Equipment, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 185 Pages | 訂單完成後即時交付

價格

依據「2030 年微載體市場預測 - 全球分析 - 產品、設備、應用和最終用戶」的最新研究，該市場預計將從 2022 年的 16.25 億美元增至 2030 年的 41.78 億美元。該報告強調推動市場的關鍵因素和知名參與者的發展。推動市場成長的關鍵因素是癌症和傳染病發病率上升對細胞療法的需求，以及外包細胞和基因療法製造的日益普及推動了市場成長。然而，生物製劑和細胞療法的高成本阻礙了市場成長。

在微載體市場營運的公司專注於策略發展，例如合作、擴張、協議、夥伴關係和新產品發布，這有助於他們提高銷售額、擴大地理覆蓋範圍並增強能力，以滿足比現有客戶群更大的需求。以下提到了微載體市場的一些值得注意的發展：

2023年10月，可樂麗株式會社開發出用於再生醫學細胞培養的PVA水凝膠微載體。該產品計劃於 2024 年 1 月在日本和海外推出，首先從美國推出。

2023 年 6 月，帝人前沿推出了新型非織造微載體，可實現快速、大規模、高品質的細胞培養。新型非織造微載體結合了帝人前沿的專有纖維工藝和非織造設計技術，以及日本福井大學工程學院的纖維相關生物醫學專業知識。

2023 年 10 月，Semarion 推出了 SemaCyte 微載體平台的早期採用者計畫。 Semarion 開發的 SemaCytes 是利用微晶片製造技術、奈米磁性和智慧材料創建的細胞載體材料。這些分析微載體是扁平的，具有超小型磁控孔的功能，可將貼壁細胞的小集落帶入懸浮液中，以改善基於細胞的實驗。

2022 年 1 月，富士膠片公司宣布計劃從 Atara Biotherapeutics, Inc. 收購一家細胞療法製造工廠。該工廠易於擴展且靈活，可生產臨床和商業細胞療法，包括同種異體 T 細胞和 CAR T 免疫療法。

2021 年 1 月，賽默飛世爾科技公司收購了 Groupe Novasep SAS 旗下位於比利時的病毒載體製造業 Henogen SA。 Henogen 為生物技術公司和大型生物製藥客戶提供疫苗和治療藥物製造服務。透過此次收購，賽默飛世爾科技擴大了在細胞和基因疫苗及療法領域的能力。

因此，推出PVA水凝膠微載體、非織造微載體和SemaCyte微載體平台等產品，並透過合作和夥伴關係啟動新業務以維持市場競爭力，將為微載體市場創造重大成長機會。

根據產品，微載體市場分為微載體珠和培養基和試劑。 2022 年，微載體珠細分市場佔據最大的市場佔有率，預計 2022-2030 年CAGR最快，達到 12.8%。不斷成長的細胞生物學研究、對再生醫學和生物製藥的需求以及多家製造商和供應商的存在促成了可觀的市場成長。廣泛的產品供應和微載體技術的不斷發展為主要市場參與者的發展提供了有利可圖的機會。 Sartorius AG 等大公司提供不含動物成分和包被蛋白質的微載體珠。

依設備，微載體市場分為生物反應器、培養容器等。 2022年，生物反應器領域佔最大的市場佔有率，預計2022-2030年複合CAGR最快，達到12.8%。生物反應器是進行生物反應的製造裝置或容器；它們用於在受控條件下的適當環境中培養酵母、細菌或動物細胞等微生物。它們維持細胞生長和產物形成的支持環境。基於微載體的生物反應器可以即時離線監測細胞生長和品質以及代謝物分析，可用於檢測錯誤並立即糾正。

根據應用，微載體市場分為生物製藥生產、細胞和基因治療、組織工程和再生醫學等。 2022年，生物製藥生產領域佔最大的市場佔有率，預計2022-2030年複合CAGR最快，達到13.1%。生物製藥生產部門進一步細分為治療藥物生產和疫苗生產。微載體是生物製藥行業的成熟技術，與攪拌槽生物反應器相結合，可以為貼壁細胞的大規模生產提供必要的環境。用於生產微載體的可生物分解材料具有解決體外疾病模型的能力。微載體在生物製藥行業中得到應用，因為它們擴大了可控生物分解的範圍。

根據最終用戶，微載體市場分為製藥和生物技術公司、合約研究組織和合約製造組織（CMO）以及學術和研究機構。到 2022 年，製藥和生物技術公司領域佔據了最大的市場佔有率。此外，預計在預測期內該領域的CAGR最高，為 12.9%。製藥公司在藥品總產量中佔有主要佔有率。藥品製造過程通常基於生物技術原理，涉及使用細菌生產胰島素、人類生長激素等產品。過去十年，製藥和生物技術行業取得了廣泛成長，這主要歸功於研發活動的增加以及引入新微生物產品的監管批准。如此大規模的創新預計將在未來幾年推動生物反應器在製藥和生物技術製造中的採用，最終有利於製藥和生物技術領域的微載體市場成長。

美國食品藥物管理局 (USFDA)、臨床和經濟審查研究所 (ICER)、疾病管制與預防中心 (CDC) 是在準備微載體市場報告時提到的幾個關鍵的主要和次要來源。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：微載體市場格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：微載體市場 - 主要產業動態

  • 主要市場促進因素：
    • 隨著癌症和傳染病發病率的上升，對細胞療法的需求
    • 外包細胞和基因治療製造越來越受歡迎
  • 市場限制
    • 生物製劑和細胞療法的高成本
  • 市場機會
    • 微載體製造商的策略性舉措和創新產品
  • 未來的趨勢
    • 細胞和基因治療製造服務的自動化
  • 影響分析

第 6 章：微載體市場 - 全球市場分析

  • 微載體市場收入，2022 - 2030

第 7 章：微載體市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年按產品分類的微載體市場收入佔有率 (%)
  • 微載體珠
  • 介質和試劑

第 8 章：微載體市場 - 收入和 2030 年預測 - 按設備

  • 概述
  • 2022 年及 2030 年按設備分類的微載體市場收入佔有率 (%)
  • 生物反應器
  • 培養容器
  • 其他

第 9 章：微載體市場 - 收入和 2030 年預測 -按應用

  • 概述
  • 2022 年和 2030 年按應用分類的微載體市場收入佔有率 (%)
  • 生物製藥生產
  • 細胞和基因治療
  • 組織工程與再生醫學
  • 其他

第 10 章：微載體市場收入和 2030 年預測 - 最終用戶

  • 概述
  • 按最終用戶分類的全球微載體市場佔有率 - 2022 年和 2030 年 (%)
  • 製藥和生物技術公司
    • 概述
  • 合約研究組織和合約製造組織
    • 概述
  • 學術及研究機構
    • 概述

第 11 章：微載體市場收入和 2028 年預測 - 地理分析

  • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：微載體市場-產業格局

  • 概述
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • denovoMATRIX GmbH
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Percell Biolytica AB
  • Asahi Kasei Corp
  • Polysciences Inc

第 14 章：附錄

  • 關於 Insight Partners
  • 專業術語
Product Code: TIPBT00002183

According to our latest study on "Microcarriers Market Forecast to 2030 - Global Analysis -Product, Equipment, Application, and End User," the market is expected to reach US$ 4.178 billion in 2030 from US$ 1.625 billion in 2022. The report highlights the key factors driving the market and prominent players with their developments. Key factors driving the market growth are need for cell therapies with rising incidence of cancer and infectious diseases, and increasing popularity of outsourcing cell and gene therapy manufacturing boost the market growth. However, the high cost of biologics and cell-based therapies hampers the market growth.

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned below:

In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US.

In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier's proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan.

In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments.

In January 2022, FUJIFILM Corporation announced its plan to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. The facility is readily expandable and flexible to produce clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies.

In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category.

Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

Based on product, the microcarriers market is divided into microcarrier beads and media & reagents. In 2022, the microcarrier beads segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022-2030. Growing cell biology research, demand for regenerative medicines and biopharmaceuticals, and the presence of multiple manufacturers and suppliers contribute to the considerable market growth. Extensive product offerings and continuous developments in microcarrier technology offer lucrative opportunities for the growth of key market players. Major companies such as Sartorius AG offer microcarrier beads that are free of animal components and proteins coated.

Based on equipment, the microcarriers market is segmented into bioreactors, culture vessels, and others. In 2022, the bioreactors segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022-2030. Bioreactors are manufacturing devices or vessels in which biological reactions are carried out; they are used to grow microorganisms such as yeast, bacteria, or animal cells in an appropriate environment under controlled conditions. They maintain a supportable environment for cell growth and product formation. A microcarrier-based bioreactor allows real-time off-line monitoring of cell growth and quality and metabolite analyses, which can be utilised to detect errors and rectify them immediately.

Based on application, the microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. In 2022, the biopharmaceutical production segment held the largest market share, and same is estimated to register the fastest CAGR of 13.1% during 2022-2030. Biopharmaceutical production segment is further subsegmented into therapeutic production and vaccine production. Microcarriers are an established technology in the biopharmaceutical industry, which, in combination with stirred-tank bioreactors, can provide the necessary environment for large-scale production of adherent cells. Biodegradable materials used in the production of microcarriers have the capability to solve in vitro disease modeling. Microcarriers find applications in biopharmaceutical industries as they expand the spectrum of controllable biodegradation.

Based on end user, the microcarriers market is segmented pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations (CMOs), and academic and research institutes. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022. Moreover, the same is estimated to register the highest CAGR of 12.9% in the market during the forecast period. Pharmaceutical companies hold a major share of the total medicine production. Pharmaceutical manufacturing processes are often based on biotechnology principles that involve the use of bacteria to produce insulin, human growth hormone, etc., products. The pharmaceutical and biotechnological industries have witnessed extensive growth in the past decade mainly owing to increased R&D activities and regulatory approvals for the introduction of new microbe-based products. Such a massive scale of innovation is projected to drive the adoption of bioreactors in pharmaceutical and biotechnological manufacturing in the coming years, eventually favoring the microcarriers market growth for the pharmaceutical and biotechnological segment.

United States Food and Drug Administration (USFDA), Institute for Clinical and Economic Review (ICER), Centers for Disease Control and Prevention (CDC), are a few key primary and secondary sources referred to while preparing the report on the microcarriers market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Microcarriers Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Microcarriers Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Microcarriers Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Microcarriers Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Biologics and Cell-based Therapies
  • 5.3 Market Opportunities
    • 5.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 5.4 Future Trends
    • 5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 5.5 Impact Analysis

6. Microcarriers Market - Global Market Analysis

  • 6.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

7. Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Microcarrier Beads
    • 7.3.1 Overview
    • 7.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Media and Reagents
    • 7.4.1 Overview
    • 7.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 8.3 Bioreactors
    • 8.3.1 Overview
    • 8.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Culture Vessels
    • 8.4.1 Overview
    • 8.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 9.3 Biopharmaceutical Production
    • 9.3.1 Overview
    • 9.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cell and Gene Therapy
    • 9.4.1 Overview
    • 9.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Tissue Engineering and Regenerative Medicine
    • 9.5.1 Overview
    • 9.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

10. Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 10.1 Overview
  • 10.2 Global Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Overview
    • 10.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 10.4.1 Overview
    • 10.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Academic and Research Institutes
    • 10.5.1 Overview
    • 10.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

11. Microcarriers Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 11.1 North America Microcarriers Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America: Microcarriers Market, by Product
    • 11.1.4 North America: Microcarriers Market, by Equipment
    • 11.1.5 North America: Microcarriers Market, by Application
      • 11.1.5.1 North America: Microcarriers Market, by Biopharmaceutical Production
    • 11.1.6 North America: Microcarriers Market, by End User
    • 11.1.7 North America: Microcarriers Market, by Country
      • 11.1.7.1 US
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.1.3 US: Microcarriers Market, by Product
        • 11.1.7.1.4 US: Microcarriers Market, by Equipment
        • 11.1.7.1.5 US: Microcarriers Market, by Application
        • 11.1.7.1.5.1 US: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.1.6 US: Microcarriers Market, by End User
      • 11.1.7.2 Canada
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.2.3 Canada: Microcarriers Market, by Product
        • 11.1.7.2.4 Canada: Microcarriers Market, by Equipment
        • 11.1.7.2.5 Canada: Microcarriers Market, by Application
        • 11.1.7.2.5.1 Canada: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.2.6 Canada: Microcarriers Market, by End User
      • 11.1.7.3 Mexico
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.3.3 Mexico: Microcarriers Market, by Product
        • 11.1.7.3.4 Mexico: Microcarriers Market, by Equipment
        • 11.1.7.3.5 Mexico: Microcarriers Market, by Application
        • 11.1.7.3.5.1 Mexico: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.3.6 Mexico: Microcarriers Market, by End User
  • 11.2 Europe Microcarriers Market, Revenue and Forecast To 2030
    • 11.2.1 Overview
    • 11.2.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe: Microcarriers Market, by Product
    • 11.2.4 Europe: Microcarriers Market, by Equipment
    • 11.2.5 Europe: Microcarriers Market, by Application
      • 11.2.5.1 Europe: Microcarriers Market, by Biopharmaceutical Production
    • 11.2.6 Europe: Microcarriers Market, by End User
    • 11.2.7 Europe: Microcarriers Market, by Country
      • 11.2.7.1 Germany
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
        • 11.2.7.1.3 Germany: Microcarriers Market, by Product
        • 11.2.7.1.4 Germany: Microcarriers Market, by Equipment
        • 11.2.7.1.5 Germany: Microcarriers Market, by Application
        • 11.2.7.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.1.6 Germany: Microcarriers Market, by End User
      • 11.2.7.2 UK
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.2.3 UK: Microcarriers Market, by Product
        • 11.2.7.2.4 UK: Microcarriers Market, by Equipment
        • 11.2.7.2.5 UK: Microcarriers Market, by Application
        • 11.2.7.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.2.6 UK: Microcarriers Market, by End User
      • 11.2.7.3 France
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.3.3 France: Microcarriers Market, by Product
        • 11.2.7.3.4 France: Microcarriers Market, by Equipment
        • 11.2.7.3.5 France: Microcarriers Market, by Application
        • 11.2.7.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.3.6 France: Microcarriers Market, by End User
      • 11.2.7.4 Italy
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
        • 11.2.7.4.3 Italy: Microcarriers Market, by Product
        • 11.2.7.4.4 Italy: Microcarriers Market, by Equipment
        • 11.2.7.4.5 Italy: Microcarriers Market, by Application
        • 11.2.7.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.4.6 Italy: Microcarriers Market, by End User
      • 11.2.7.5 Spain
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.5.3 Spain: Microcarriers Market, by Product
        • 11.2.7.5.4 Spain: Microcarriers Market, by Equipment
        • 11.2.7.5.5 Spain: Microcarriers Market, by Application
        • 11.2.7.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.5.6 Spain: Microcarriers Market, by End User
      • 11.2.7.6 Rest of Europe
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.6.3 Rest of Europe: Microcarriers Market, by Product
        • 11.2.7.6.4 Rest of Europe: Microcarriers Market, by Equipment
        • 11.2.7.6.5 Rest of Europe: Microcarriers Market, by Application
        • 11.2.7.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.6.6 Rest of Europe: Microcarriers Market, by End User
  • 11.3 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
    • 11.3.1 Overview
    • 11.3.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific: Microcarriers Market, by Product
    • 11.3.4 Asia Pacific: Microcarriers Market, by Equipment
    • 11.3.5 Asia Pacific: Microcarriers Market, by Application
      • 11.3.5.1 Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
    • 11.3.6 Asia Pacific: Microcarriers Market, by End User
    • 11.3.7 Asia Pacific: Microcarriers Market, by Country
      • 11.3.7.1 China
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
        • 11.3.7.1.3 China: Microcarriers Market, by Product
        • 11.3.7.1.4 China: Microcarriers Market, by Equipment
        • 11.3.7.1.5 China: Microcarriers Market, by Application
        • 11.3.7.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.1.6 China: Microcarriers Market, by End User
      • 11.3.7.2 Japan
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.2.3 Japan: Microcarriers Market, by Product
        • 11.3.7.2.4 Japan: Microcarriers Market, by Equipment
        • 11.3.7.2.5 Japan: Microcarriers Market, by Application
        • 11.3.7.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.2.6 Japan: Microcarriers Market, by End User
      • 11.3.7.3 India
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.3.3 India: Microcarriers Market, by Product
        • 11.3.7.3.4 India: Microcarriers Market, by Equipment
        • 11.3.7.3.5 India: Microcarriers Market, by Application
        • 11.3.7.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.3.6 India: Microcarriers Market, by End User
      • 11.3.7.4 Australia
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 11.3.7.4.3 Australia: Microcarriers Market, by Product
        • 11.3.7.4.4 Australia: Microcarriers Market, by Equipment
        • 11.3.7.4.5 Australia: Microcarriers Market, by Application
        • 11.3.7.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.4.6 Australia: Microcarriers Market, by End User
      • 11.3.7.5 South Korea
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.5.3 South Korea: Microcarriers Market, by Product
        • 11.3.7.5.4 South Korea: Microcarriers Market, by Equipment
        • 11.3.7.5.5 South Korea: Microcarriers Market, by Application
        • 11.3.7.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.5.6 South Korea: Microcarriers Market, by End User
      • 11.3.7.6 Rest of Asia Pacific
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
        • 11.3.7.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
        • 11.3.7.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
        • 11.3.7.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.6.6 Rest of Asia Pacific: Microcarriers Market, by End User
  • 11.4 Middle East & Africa Microcarriers Market, Revenue and Forecast To 2030
    • 11.4.1 Overview
    • 11.4.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa: Microcarriers Market, by Product
    • 11.4.4 Middle East & Africa: Microcarriers Market, by Equipment
    • 11.4.5 Middle East & Africa: Microcarriers Market, by Application
      • 11.4.5.1 Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
    • 11.4.6 Middle East & Africa: Microcarriers Market, by End User
    • 11.4.7 Middle East & Africa: Microcarriers Market, by Country
      • 11.4.7.1 Saudi Arabia
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
        • 11.4.7.1.3 Saudi Arabia: Microcarriers Market, by Product
        • 11.4.7.1.4 Saudi Arabia: Microcarriers Market, by Equipment
        • 11.4.7.1.5 Saudi Arabia: Microcarriers Market, by Application
        • 11.4.7.1.5.1 Saudi Arabia: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.1.6 Saudi Arabia: Microcarriers Market, by End User
      • 11.4.7.2 South Africa
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.2.3 South Africa: Microcarriers Market, by Product
        • 11.4.7.2.4 South Africa: Microcarriers Market, by Equipment
        • 11.4.7.2.5 South Africa: Microcarriers Market, by Application
        • 11.4.7.2.5.1 South Africa: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.2.6 South Africa: Microcarriers Market, by End User
      • 11.4.7.3 UAE
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.3.3 UAE: Microcarriers Market, by Product
        • 11.4.7.3.4 UAE: Microcarriers Market, by Equipment
        • 11.4.7.3.5 UAE: Microcarriers Market, by Application
        • 11.4.7.3.5.1 UAE: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.3.6 UAE: Microcarriers Market, by End User
      • 11.4.7.4 Rest Middle East & Africa
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 11.4.7.4.3 Rest Middle East & Africa: Microcarriers Market, by Product
        • 11.4.7.4.4 Rest Middle East & Africa: Microcarriers Market, by Equipment
        • 11.4.7.4.5 Rest Middle East & Africa: Microcarriers Market, by Application
        • 11.4.7.4.5.1 Rest Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.4.6 Rest Middle East & Africa: Microcarriers Market, by End User
  • 11.5 South & Central America Microcarriers Market, Revenue and Forecast To 2030
    • 11.5.1 Overview
    • 11.5.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America: Microcarriers Market, by Product
    • 11.5.4 South & Central America: Microcarriers Market, by Equipment
    • 11.5.5 South & Central America: Microcarriers Market, by Application
      • 11.5.5.1 South & Central America: Microcarriers Market, by Biopharmaceutical Production
    • 11.5.6 South & Central America: Microcarriers Market, by End User
    • 11.5.7 South & Central America: Microcarriers Market, by Country
      • 11.5.7.1 Brazil
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
        • 11.5.7.1.3 Brazil: Microcarriers Market, by Product
        • 11.5.7.1.4 Brazil: Microcarriers Market, by Equipment
        • 11.5.7.1.5 Brazil: Microcarriers Market, by Application
        • 11.5.7.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.1.6 Brazil: Microcarriers Market, by End User
      • 11.5.7.2 Argentina
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.2.3 Argentina: Microcarriers Market, by Product
        • 11.5.7.2.4 Argentina: Microcarriers Market, by Equipment
        • 11.5.7.2.5 Argentina: Microcarriers Market, by Application
        • 11.5.7.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.2.6 Argentina: Microcarriers Market, by End User
      • 11.5.7.3 Rest Of South & Central America
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.3.3 Rest Of South & Central America: Microcarriers Market, by Product
        • 11.5.7.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment
        • 11.5.7.3.5 Rest Of South & Central America: Microcarriers Market, by Application
        • 11.5.7.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.3.6 Rest Of South & Central America: Microcarriers Market, by End User

12. Microcarriers Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Organic Growth Strategies
    • 12.2.1 Overview
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview

13. Company Profiles

  • 13.1 Teijin Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Bio-Rad Laboratories Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 denovoMATRIX GmbH
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sartorius AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Danaher Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Corning Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Eppendorf SE
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Percell Biolytica AB
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Asahi Kasei Corp
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Polysciences Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. North America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. North America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. North America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. North America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. North America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. US Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. US Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. US Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. US Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. US: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. Canada Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. Canada Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. Canada Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. Canada Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. Canada: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Mexico Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Mexico Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Mexico Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Mexico Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Mexico: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Germany Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Germany Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Germany Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Germany Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. UK Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 33. UK Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 34. UK Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 35. UK Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 36. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 37. France Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 38. France Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 39. France Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 40. France Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 41. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 42. Italy Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 43. Italy Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 44. Italy Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 45. Italy Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 46. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 47. Spain Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 48. Spain Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 49. Spain Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 50. Spain Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 51. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 52. Rest of Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 53. Rest of Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 54. Rest of Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 55. Rest of Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 56. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 57. Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 58. Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 59. Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 60. Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 61. Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 62. China Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 63. China Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 64. China Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 65. China Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 66. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 67. Japan Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 68. Japan Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 69. Japan Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 70. Japan Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 71. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 72. India Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 73. India Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 74. India Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 75. India Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 76. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 77. Australia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 78. Australia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 79. Australia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 80. Australia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 81. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 82. South Korea Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 83. South Korea Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 84. South Korea Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 85. South Korea Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 86. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 87. Rest of Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 88. Rest of Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 89. Rest of Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 90. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 91. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 92. Middle East & Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 93. Middle East & Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 94. Middle East & Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 95. Middle East & Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 96. Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 97. Saudi Arabia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 98. Saudi Arabia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 99. Saudi Arabia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 100. Saudi Arabia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 101. Saudi Arabia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 102. South Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 103. South Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 104. South Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 105. South Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 106. South Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 107. UAE Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 108. UAE Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 109. UAE Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 110. UAE Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 111. UAE: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 112. Rest Middle East & Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 113. Rest Middle East & Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 114. Rest Middle East & Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 115. Rest Middle East & Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 116. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 117. South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 118. South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 119. South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 120. South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 121. South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 122. Brazil Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 123. Brazil Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 124. Brazil Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 125. Brazil Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 126. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 127. Argentina Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 128. Argentina Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 129. Argentina Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 130. Argentina Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 131. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 132. Rest Of South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 133. Rest Of South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 134. Rest Of South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 135. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 136. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 137. Recent Organic Growth Strategies in Microcarriers Market
  • Table 138. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 139. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Region
  • Figure 2. Key Insights
  • Figure 3. Global - PEST Analysis
  • Figure 4. Microcarriers Market - Key Industry Dynamics
  • Figure 5. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 6. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 7. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 11. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 15. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Global Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 22. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 25. Microcarriers Market, 2022 ($Mn)
  • Figure 26. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. North America: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 28. US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Microcarriers Market, 2022 ($Mn)
  • Figure 32. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 34. Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
  • Figure 35. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
  • Figure 38. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Microcarriers Market, 2022 ($Mn)
  • Figure 41. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 43. China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
  • Figure 44. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
  • Figure 47. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Microcarriers Market, 2022 ($Mn)
  • Figure 50. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Middle East & Africa: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 52. Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
  • Figure 53. South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
  • Figure 56. Microcarriers Market, 2022 ($Mn)
  • Figure 57. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. South & Central America: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 59. Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
  • Figure 60. Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)